Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma
- PMID: 16843635
- DOI: 10.1016/j.ejso.2006.05.019
Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma
Abstract
Aim: This study was performed to assess in the accurate evaluation of primary colorectal carcinoma using PET/CT.
Methods: One hundred patients with primary colorectal carcinoma were evaluated during 2004. All patients underwent PET/CT when their preoperative serum carcinoembryonic antigen was >or=10 ng/mL or when CT showed equivocal findings. The appropriateness of PET/CT-induced changes was noted by subsequent operative findings and follow-up.
Results: PET/CT more detected 15 intra-abdominal metastatic lesions than abdomino-pelvic CT scan. PET/CT showed true negative findings in 13 patients and false positive or negative findings in 10. Due to PET/CT results, management plans were altered in 27 patients; 9 had inter-modality changes, 10 received more extensive surgery, and 8 avoided unnecessary procedures.
Conclusions: PET/CT altered management plan in 24% of patients with primary colorectal carcinoma in correct direction. These findings suggest that PET/CT should be considered a part of standard work up for preoperative evaluation in a subset of patients with colorectal carcinoma.
Similar articles
-
Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.Arch Surg. 1999 May;134(5):503-11; discussion 511-3. doi: 10.1001/archsurg.134.5.503. Arch Surg. 1999. PMID: 10323422 Clinical Trial.
-
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].Pol Merkur Lekarski. 2004;17 Suppl 1:63-6. Pol Merkur Lekarski. 2004. PMID: 15603351 Clinical Trial. Polish.
-
The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.J Nucl Med. 2002 Apr;43(4):492-9. J Nucl Med. 2002. PMID: 11937593
-
Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT.Abdom Imaging. 2008 May-Jun;33(3):270-7. doi: 10.1007/s00261-007-9262-9. Abdom Imaging. 2008. PMID: 17610107 Review.
-
[Combined functional and morphological imaging with PET/CT systems].Praxis (Bern 1994). 2003 Feb 5;92(6):225-7. doi: 10.1024/0369-8394.92.6.225. Praxis (Bern 1994). 2003. PMID: 12645384 Review. German. No abstract available.
Cited by
-
Positron emission tomography for benign and malignant disease.Surg Clin North Am. 2011 Feb;91(1):249-66. doi: 10.1016/j.suc.2010.10.012. Surg Clin North Am. 2011. PMID: 21184913 Free PMC article. Review.
-
Preoperative 18F-FDG PET/CT in Patients with Presumed Localized Colon Cancer: A Prospective Study with Long-Term Follow-Up.Cancers (Basel). 2024 Jan 4;16(1):233. doi: 10.3390/cancers16010233. Cancers (Basel). 2024. PMID: 38201660 Free PMC article.
-
Is 18F-FDG PET/CT an Accurate Way to Detect Lymph Node Metastasis in Colorectal Cancer: A Systematic Review and Meta-Analysis.Contrast Media Mol Imaging. 2020 Jul 18;2020:5439378. doi: 10.1155/2020/5439378. eCollection 2020. Contrast Media Mol Imaging. 2020. PMID: 32733174 Free PMC article.
-
Magnetic Resonance Imaging Evaluation in Neoadjuvant Therapy of Locally Advanced Rectal Cancer: A Systematic Review.Radiol Oncol. 2017 Aug 16;51(3):252-262. doi: 10.1515/raon-2017-0032. eCollection 2017 Sep. Radiol Oncol. 2017. PMID: 28959161 Free PMC article.
-
Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients.BMC Cancer. 2021 Mar 9;21(1):258. doi: 10.1186/s12885-021-07944-z. BMC Cancer. 2021. PMID: 33750337 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical